With the analysis among 38 patents, we discovered top 27 key players by total patent application. Beijing Marr Bio-Pharmaceutical Co. Ltd., Chemclin Diagnostics Co., Ltd., NewScen Coast Bio Pharmaceutical Co. Ltd. are dominant in this area. They take 23.68% of the total patent filing.
Beijing Shi, China
Patent: 3
Chemclin Diagnostics Co., Ltd.
Beijing Shi, China
Patent: 3
Tianjin Shi, China
Patent: 3
Connecticut, United States
Patent: 3
California, United States
Patent: 3
Shanghai Shi, China
Patent: 2
Beijing Shi, China
Patent: 2
California, United States
Patent: 1
Henan Sheng, China
Patent: 1
No data, please try another search term
With the analysis among related 23 patents applied in the last 5 years. We discover 16 most active companies in this area. The fast-growing Grifols Diagnostic Solutions, Inc., Beijing Marr Bio-Pharmaceutical Co. Ltd., Chemclin Diagnostics Co., Ltd. take 34.78% of patent filing during this period.
California, United States
Patent: 3
Beijing Shi, China
Patent: 3
Chemclin Diagnostics Co., Ltd.
Beijing Shi, China
Patent: 2
Beijing Shi, China
Patent: 2
Shanghai Shi, China
Patent: 2
California, United States
Patent: 1
New York, United States
Patent: 1
Henan Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
With the analysis among related 23 patents in last 5 years, we discover 15 new entrants. Grifols Diagnostic Solutions, Inc., Beijing Marr Bio-Pharmaceutical Co. Ltd., Beijing Liangxin Biotechnology Development Co., Ltd. are the most active new entrants in this area.
California, United States
Patent: 3
Beijing Shi, China
Patent: 3
Beijing Shi, China
Patent: 2
Shanghai Shi, China
Patent: 2
California, United States
Patent: 1
New York, United States
Patent: 1
Henan Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Fred Hutchinson Cancer Research Center
Washington, United States
Patent: 1
With the analysis among 13 patents, we discovered top 2 universities and scientific research institutions by total patent application.
New York, United States
Patent: 1
Hubei Sheng, China
Patent: 1